Stock Markets March 30, 2026

Stocks See Broad Moves; Exxon Mobil and PepsiCo Rise While Micron, Several Tech Names Slip

Mega-, large-, mid- and small-cap names registered notable gains and losses across sectors during Monday trading

By Leila Farooq MU GEV LRCX AMAT
Stocks See Broad Moves; Exxon Mobil and PepsiCo Rise While Micron, Several Tech Names Slip
MU GEV LRCX AMAT

Monday's session produced a wide range of stock moves across market-cap tiers. Among mega-cap equities, Exxon Mobil and PepsiCo advanced while Micron Technology and several other large names fell. The large-, mid- and small-cap universes also posted mixed results, with steep declines in some names and double-digit gains in others.

Key Points

  • Mega-cap names showed mixed performance - Exxon Mobil and PepsiCo rose while Micron and several industrial and tech giants fell.
  • Large-cap movers included deal-related news for Sysco and analyst actions affecting Boston Scientific, alongside strong gains for Alcoa and United Therapeutics tied to trial results.
  • Mid- and small-cap lists displayed wide volatility, with some companies plunging by double digits while others reported sizable one-day gains.

Stocks across market-cap buckets moved sharply on Monday, with momentum diverging between energy and consumer staples winners and a swath of technology and specialty names trading lower. Below is a categorized rundown of the most pronounced movers, preserving reported price changes and company-specific notes where provided.


Mega-Cap Movers (Market Cap $200B+ USD)

  • Micron Tech (MU) -4.82%
  • GE Vernova LLC (GEV) -3.65%
  • Lam Research Corp (LRCX) -3.5%
  • Applied Matls Inc (AMAT) -2.37%
  • General Electric (GE) -2.8%
  • Caterpillar (CAT) -2.21%
  • Exxon Mobil (XOM) +1.71%
  • Pepsico (PEP) +2.42%

Large-Cap Stock Movers (Market Cap $10-$200B USD)

  • Sysco Corp (SYY); Sysco nearing deal for Restaurant Depot for $29B including debt - WSJ -12.19%
  • Bloom Energy Corp (BE) -9.53%
  • Boston Scien Cp (BSX); Raymond James downgrades Boston Scientific stock rating on growth concerns -8.1%
  • Ciena (CIEN) -6.77%
  • Coherent (COHR) -5.27%
  • Astera Labs (ALAB) -7.18%
  • Regencell Bioscience Holdings (RGC) -6.54%
  • PayPay Corp (PAYP) -10.59%
  • Alcoa (AA) +11.71%
  • United Therapeutics Corp (UTHR); United Therapeutics’ Tyvaso meets primary endpoint in IPF trial +14.78%

Mid-Cap Stock Movers (Market Cap $2-$10B USD)

  • Signal Genetics (VRDN); Viridian reports positive phase 3 trial results for TED drug -33.79%
  • Fundrise Innovation Fund (VCX) -32.51%
  • Fermi America LLC (FRMI) -20.47%
  • nLIGHT Inc (LASR) -11.88%
  • Applied Opt (AAOI) -12.42%
  • Nexstar Broadcast (NXST) -8.78%
  • Veradermics Inc (MANE) -5.42%
  • Calumet Specialty (CLMT) +11.62%
  • Century Aluminum Co (CENX) +10.83%

Small-Cap Stock Movers (Market Cap $300M-$2B USD)

  • Roma Green Finance (ROMA); Roma Green Finance authorizes $100M share buyback program -40.95%
  • CF Acquisition V (SATL); Cantor sees NASA initiatives boosting Rocket Lab, Intuitive Machines -14.17%
  • Newsmax (NMAX) -9.95%
  • Pegasus Digital Mobility (SHMD) -9.45%
  • Neumora Therapeutics (NMRA); Neumora beats Q4 earnings expectations amid pipeline progress, stock falls 2% -10.75%
  • Bleichroeder Acquisition I (MRLN) -11.53%
  • Anbio Biotechnology (NNNN) +7.02%
  • Compass Diversified Holdings (CODI); Compass Diversified to sell Sterno food service unit for $292.5M +14.0%
  • IQIYI Inc (IQ); iQIYI plans Hong Kong listing, approves $100M buyback program +9.1%
  • Sigma Lithium US (SGML) +21.22%

These moves span multiple sectors, with energy and consumer staples among the mega-cap gainers while semiconductor and industrial-related names led declines in the larger-cap tier. Mid- and small-cap lists contain several extreme percentage moves, both positive and negative, reflecting idiosyncratic corporate developments and deal-related headlines called out in the reporting.

For readers seeking continuous, real-time coverage and market-driving news, a subscription to a dedicated market news service was suggested in the original reporting.

Risks

  • Company-specific news and deal reports can drive large price swings in affected sectors such as foodservice (Sysco) and specialty industrials.
  • Clinical trial outcomes and regulatory updates create pronounced short-term moves in biotech and pharmaceutical stocks, impacting the healthcare sector.
  • Buyback announcements and corporate restructurings can produce abrupt reactions in small-cap names, increasing volatility for investors in that segment.

More from Stock Markets

UPS, Teamsters Agree to Cap Severance Offers for Drivers at 7,500 Apr 5, 2026 Asia Markets Cautious as Trump Sets Deadline for Strait of Hormuz, Oil Rises and Bonds Slide Apr 5, 2026 Wall Street Futures Slip as Trump Sets Deadline for Iran to Reopen Strait of Hormuz Apr 5, 2026 Samsung Electronics Poised for Record Quarterly Operating Profit as Memory Prices Soar Apr 5, 2026 Gulf Sovereign Funds Commit About $24 Billion to Back Paramount Skydance's Bid for Warner Bros. Discovery Apr 5, 2026